A detailed history of Asset Management One Co., Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 1,145,397 shares of JNJ stock, worth $190 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
1,145,397
Previous 1,175,570 2.57%
Holding current value
$190 Million
Previous $186 Million 9.98%
% of portfolio
0.65%
Previous 0.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$144.38 - $157.78 $4.36 Million - $4.76 Million
-30,173 Reduced 2.57%
1,145,397 $167 Million
Q1 2024

May 02, 2024

SELL
$155.22 - $162.74 $6.22 Million - $6.52 Million
-40,041 Reduced 3.29%
1,175,570 $186 Million
Q4 2023

Jan 24, 2024

SELL
$145.6 - $158.88 $11.4 Million - $12.5 Million
-78,505 Reduced 6.07%
1,215,611 $191 Million
Q3 2023

Oct 19, 2023

SELL
$155.75 - $174.48 $13 Million - $14.6 Million
-83,451 Reduced 6.06%
1,294,116 $202 Million
Q2 2023

Jul 31, 2023

BUY
$154.35 - $166.11 $1.89 Million - $2.03 Million
12,225 Added 0.9%
1,377,567 $228 Million
Q1 2023

Apr 25, 2023

BUY
$151.05 - $180.26 $1.78 Million - $2.12 Million
11,785 Added 0.87%
1,365,342 $212 Million
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $5.56 Million - $6.24 Million
-34,692 Reduced 2.5%
1,353,557 $239 Million
Q3 2022

Nov 04, 2022

SELL
$161.33 - $179.52 $4.42 Million - $4.92 Million
-27,386 Reduced 1.93%
1,388,249 $227 Million
Q2 2022

Jul 29, 2022

BUY
$168.19 - $186.01 $1.52 Million - $1.68 Million
9,015 Added 0.64%
1,415,635 $251 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $9.95 Million - $11.3 Million
-62,889 Reduced 4.28%
1,406,620 $249 Million
Q4 2021

Feb 09, 2022

SELL
$155.93 - $173.01 $1.32 Million - $1.46 Million
-8,465 Reduced 0.57%
1,469,509 $252 Million
Q3 2021

Nov 02, 2021

SELL
$161.5 - $179.47 $8.38 Million - $9.31 Million
-51,871 Reduced 3.39%
1,477,974 $239 Million
Q2 2021

Aug 03, 2021

SELL
$159.48 - $171.07 $6.57 Million - $7.05 Million
-41,184 Reduced 2.62%
1,529,845 $252 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $5.87 Million - $6.54 Million
-38,353 Reduced 2.38%
1,571,029 $258 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $2.74 Million - $3.14 Million
19,958 Added 1.26%
1,609,382 $248 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $4.04 Million - $4.43 Million
-28,807 Reduced 1.78%
1,589,424 $237 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $825,543 - $996,663
-6,409 Reduced 0.39%
1,618,231 $228 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $3.81 Million - $5.28 Million
-34,311 Reduced 2.07%
1,624,640 $213 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $935,977 - $1.08 Million
7,341 Added 0.44%
1,658,951 $242 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $2.65 Million - $2.96 Million
20,850 Added 1.28%
1,651,610 $214 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $14 Million - $15.4 Million
107,000 Added 7.02%
1,630,760 $227 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $379 Million - $422 Million
-3,017,744 Reduced 66.45%
1,523,760 $213 Million
Q4 2018

Feb 13, 2019

BUY
$122.84 - $147.84 $6.1 Million - $7.34 Million
49,643 Added 1.11%
4,541,504 $586 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $4.33 Million - $5.09 Million
35,623 Added 0.8%
4,491,861 $621 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $4.52 Million - $4.99 Million
37,841 Added 0.86%
4,456,238 $541 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $1.24 Million - $1.46 Million
9,880 Added 0.22%
4,418,397 $566 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $15.3 Million - $16.7 Million
-116,439 Reduced 2.57%
4,408,517 $616 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $12.4 Million - $12.9 Million
95,627 Added 2.16%
4,524,956 $588 Million
Q2 2017

Aug 14, 2017

BUY
N/A
4,429,329
4,429,329 $586 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.